C. Beuscart
Impact in
-
- Nosocomial Infections in ICU
-
- Antibiotic Use and Resistance
Papers in
- Epidemiology 24
- Pneumonia and Respiratory Infections 12
- Pneumocystis jirovecii pneumonia detection and treatment 5
- Pharmacology 10
- Antibiotics Pharmacokinetics and Efficacy 8
- Co-authors
- O. Leroy (19 shared papers)G. Beaucaire (19 shared papers)Hugues Georges (6 shared papers)Y Mouton (24 shared papers)Benoît Guéry (6 shared papers)Ch. Santré (7 shared papers)Christian Chidiac (4 shared papers)Olivier Leroy (4 shared papers)
In The Last Decade
C. Beuscart
47 papers receiving 802 citations
Peers
Comparison fields: 5 of 67
- Critical Care and Intensive Care Medicine 141
- Applied Microbiology and Biotechnology 47
- Molecular Medicine 114
- Epidemiology 466
- Pharmacology 173
Countries citing papers authored by C. Beuscart
This map shows the geographic impact of C. Beuscart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Beuscart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Beuscart more than expected).
Fields of papers citing papers by C. Beuscart
This network shows the impact of papers produced by C. Beuscart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Beuscart. The network helps show where C. Beuscart may publish in the future.
Co-authors
The 25 scholars most cited alongside C. Beuscart, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 211 | |
| 2 | 1996 | 69 | |
| 3 | 1991 | 57 | |
| 4 | 1996 | 57 | |
| 5 | 1995 | 52 | |
| 6 | 1997 | 43 | |
| 7 | 1989 | 40 | |
| 8 | 1997 | 37 | |
| 9 | Trimethoprim-sulfamethoxazole versus aerosolized pentamidine for primary prophylaxis of Pneumocystis carinii pneumonia: a prospective, randomized, controlled clinical trial. LFPMI Study Group. Ligue Française de Prévention des Maladies Infectieuses. | 1994 | 37 |
| 10 | 1993 | 35 | |
| 11 | 1995 | 32 | |
| 12 | 1993 | 31 | |
| 13 | [Evaluation of prescription of antibiotics in an intensive care unit]. | 1998 | 14 |
| 14 | 1996 | 14 | |
| 15 | 1990 | 10 | |
| 16 | [Evaluation of ciprofloxacin versus amoxicillin + clavulanic acid or erythromycin for the empiric treatment of community-acquired pneumonia]. | 1991 | 9 |
| 17 | [Treatment of pneumonia caused by Legionella, Mycoplasma, Chlamydiae and Rickettsia using ofloxacin]. | 1989 | 9 |
| 18 | [Cardiac hydatidosis: contribution of magnetic resonance imaging. Report of a case]. | 1990 | 9 |
| 19 | [Infectious endocarditis of the tricuspid valve in patients with endocardial pacemakers]. | 1990 | 7 |
| 20 | 1996 | 6 |
About C. Beuscart
C. Beuscart is a scholar working on Epidemiology, Pharmacology, Surgery, Molecular Medicine and Applied Microbiology and Biotechnology, having authored 50 papers that have together received 845 indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (12 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers), Antibiotic Resistance in Bacteria (7 papers), Antibiotic Use and Resistance (7 papers), Bacterial Identification and Susceptibility Testing (5 papers), Nosocomial Infections in ICU (5 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers) and Streptococcal Infections and Treatments (3 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (141 citations), Applied Microbiology and Biotechnology (47 citations), Molecular Medicine (114 citations), Epidemiology (466 citations) and Pharmacology (173 citations). C. Beuscart has collaborated with scholars based in France and Belgium. Frequent co-authors include O. Leroy, G. Beaucaire, Hugues Georges, Y Mouton, Benoît Guéry, Ch. Santré, Christian Chidiac, Olivier Leroy, É. Senneville and C. Chidiac. Their work appears in journals such as Intensive Care Medicine, Journal of Antimicrobial Chemotherapy, Médecine et Maladies Infectieuses, Clinical Infectious Diseases and Clinical Microbiology and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.